Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516584 | SCV000615468 | benign | not specified | 2016-09-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000585497 | SCV000692716 | likely benign | not provided | 2025-03-01 | criteria provided, single submitter | clinical testing | SPTBN2: BP4, BS2 |
Labcorp Genetics |
RCV000585497 | SCV001068712 | likely benign | not provided | 2024-10-23 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002244993 | SCV002512503 | uncertain significance | Spinocerebellar ataxia type 5; Autosomal recessive spinocerebellar ataxia 14 | 2021-08-27 | criteria provided, single submitter | clinical testing | ACMG classification criteria: BP4 supporting |
Ambry Genetics | RCV004023525 | SCV004957122 | likely benign | Inborn genetic diseases | 2022-02-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Department of Pathology and Laboratory Medicine, |
RCV002244993 | SCV006054093 | likely benign | Spinocerebellar ataxia type 5; Autosomal recessive spinocerebellar ataxia 14 | 2021-07-30 | criteria provided, single submitter | research |